Literature DB >> 8435447

The synthesis of IL-1 receptor antagonist (IL-1ra) by synovial fibroblasts is markedly increased by the cytokines TNF-alpha and IL-1.

J Martel-Pelletier1, R McCollum, J P Pelletier.   

Abstract

The regulation of inhibitors which block the action of IL-1 has significant implications in the control of inflammation. Different modulators of cellular metabolism were studied for their effect on the synthesis of IL-1 receptor antagonist (IL-1ra). Among the different growth factors and cytokines studied, only the inflammatory mediators IL-1 and TNF-alpha and one growth factor, PDGF-BB, were found to significantly increase, in an additive manner, the synthesis and secretion of IL-1ra.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8435447     DOI: 10.1016/0167-4889(93)90221-a

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  5 in total

1.  Regulation of brain interleukin-1 beta (IL-1 beta) system mRNAs in response to pathophysiological concentrations of IL-1 beta in the cerebrospinal fluid.

Authors:  S E Ilyin; G Sonti; D Gayle; C R Plata-Salamán
Journal:  J Mol Neurosci       Date:  1996       Impact factor: 3.444

2.  Role of fibroblasts in the regulation of proinflammatory interleukin IL-1, IL-6 and IL-8 levels induced by keratinocyte-derived IL-1.

Authors:  I L Boxman; C Ruwhof; O C Boerman; C W Löwik; M Ponec
Journal:  Arch Dermatol Res       Date:  1996-06       Impact factor: 3.017

3.  Interleukin-1 (IL-1)-induced resistance to bacterial infection: role of the type I IL-1 receptor.

Authors:  M T Vogels; W M Eling; A Otten; J W van der Meer
Journal:  Antimicrob Agents Chemother       Date:  1995-08       Impact factor: 5.191

4.  The Novartis-ILAR Rheumatology Prize 2001 Osteoarthritis: from molecule to man.

Authors:  Jean-Pierre Pelletier; Johanne Martel-Pelletier
Journal:  Arthritis Res       Date:  2001-11-02

5.  Release kinetics of tumor necrosis factor-α and interleukin-1 receptor antagonist in the equine whole blood.

Authors:  Simon Rütten; Gerald F Schusser; Getu Abraham; Wieland Schrödl
Journal:  BMC Vet Res       Date:  2016-06-17       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.